CG Oncology (CGON) Gross Profit (2024 - 2026)

CG Oncology (CGON) reported Gross Profit of -$1.9 million for Q1 2026, down 3713.46% on a YoY basis from $52000.0 in Q1 2025, and down 151.2% quarter-over-quarter from -$748000.0 in Q4 2025.

CG Oncology (CGON) Gross Profit (2024 - 2026) Analysis & Trends

CG Oncology has reported Gross Profit for 3 years, with the latest figure at -$1.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Gross Profit fell 3713.46% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at -$2.5 million (changed N/A YoY), and the FY2025 full-year result was -$607000.0, down 153.29% from the prior year.
  • Gross Profit for Q1 2026 stood at -$1.9 million, down from -$748000.0 in the prior quarter.
  • The five-year high for Gross Profit was $456000.0 in Q4 2024, with the low at -$1.9 million in Q1 2026.
  • Historically, Gross Profit has averaged -$331166.7 across 3 years, with a median of $47500.0 in 2024.
  • Annual changes were most pronounced in 2025 — Gross Profit jumped 106.98% — and 2026, when it sank 3713.46%.
  • CG Oncology's Gross Profit stood at $456000.0 in 2024, then slumped by 264.04% to -$748000.0 in 2025, then sank by 151.2% to -$1.9 million in 2026.
  • The last three Gross Profit figures came in at -$1.9 million (Q1 2026), -$748000.0 (Q4 2025), and $89000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 CG Oncology 5.16 Bn 5.16 Bn -1.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.88 Mn
Mar 31, 2026 -1.88 Mn
Dec 31, 2025 -748,000.00
Dec 31, 2025 -748,000.00
Sep 30, 2025 89,000.00
Sep 30, 2025 89,000.00
Mar 31, 2025 52,000.00
Mar 31, 2025 52,000.00
Dec 31, 2024 456,000.00
Dec 31, 2024 456,000.00
Sep 30, 2024 43,000.00
Sep 30, 2024 43,000.00